Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 44
Filter
1.
Water Sci Technol ; 66(5): 918-26, 2012.
Article in English | MEDLINE | ID: mdl-22797217

ABSTRACT

Suspended sediment, which is an important water quality characteristic concerning effluents from agricultural areas, was studied in relatively small rivers that drain agricultural watersheds with considerable rice paddy areas. Suspended sediment load (SL) was observed daily for thirty three months and analysed--applying data stratification. Suspended sediment prediction models were established and the effect of rice transplanting activities on the rivers' SL was estimated. Results showed that data stratification improved the discharge-SL correlation and reduced regression and curve-fitting errors, thereby improving the efficiency of the derived model equations. Clustering the months into the rice- and non-rice transplanting seasons also improved the resulting regression equations, although not statistically significantly. Suspended SL was found to be higher during the rice transplanting season and the activities contributed a considerable amount of suspended sediment during the period, supporting the conjecture that sediments come from sources other than natural soil erosion.


Subject(s)
Agriculture , Geologic Sediments/chemistry , Oryza , Rivers/chemistry , Environmental Monitoring/methods , Japan , Models, Theoretical , Regression Analysis , Seasons
2.
Neuroradiol J ; 20(5): 551-61, 2007 Oct 31.
Article in English | MEDLINE | ID: mdl-24299945

ABSTRACT

Vein of Galen aneurysmal dilatation is generally considered an abnormal deep-seated arteriovenous shunt that drains into the Vein of Galen. We herein present three pediatric cases of vein of Galen aneurysmal dilatation (VGAD). The locations of these shunts are anatomically different from just parenchymal as previously reported, but are also cisternal and intraventricular. Clinical symptoms, neuroradiological diagnostic points and therapeutic endovascular management are reported. Three boys had abnormal findings on brain computed tomography. Using magnetic resonance images, magnetic resonance angiography, three dimensional computed tomographical angiography and digital subtraction angiography, these patients were diagnosed with VGAD. The different locations of their shunts were the intraventricular choroidal plexus, cistern verum interpositive, and thalamus pulvinar nucleus. The boy presenting a single hole arteriovenous shunt at the cistern verum interpositive and an arteriovenous malformation at the choroidal plexus in the left lateral ventricle were treated by endovascular glue embolization. The patient with a single hole fistula in the left thalamus was followed only with observation. Treated patients had their abnormal shunts closed without any neurological complications. VGADs should be classified by shunt location according to whether they are ventricular, cisternal, or parenchymal. Although the therapeutic decision for pediatric VGAD should consider individual radiological, clinical and familial factors, endovascular intervention should be chosen as a first therapeutic option. Endovascular management of these lesions result in excellent angiographic and clinical outcome.

3.
Pediatr Int ; 43(6): 587-91, 2001 Dec.
Article in English | MEDLINE | ID: mdl-11737734

ABSTRACT

BACKGROUND: To better understand the mechanisms of glomerular epithelial cell (GEC) injuries in various diseases, we compared GEC excreted during chemotherapy (antineoplastic drugs) and GEC excreted in renal diseases. METHODS: For 19 patients undergoing chemotherapy (85 courses), 69 patients with IgA nephropathy and 16 patients with Henoch-Schölein purpura nephritis, the number of excreted GEC and GEC casts were counted by an immunofluorescent study. The morphological features of GEC were also studied in an immunofluorescent study combined with Hoechst stain. RESULTS: Glomerular epithelial cells were detected in 78% of the chemotherapy courses and in 94% of the patients with renal diseases. The GEC casts were observed in 2% of chemotherapy courses, while in renal diseases GEC casts were observed in 60% of the patients. Proteinuria (>30 mg/dL) and hematuria were not identified in any of the chemotherapy courses. The morphology and size of GEC were more variable than that in patients with nephropathy. Furthermore, GEC in patients undergoing chemotherapy often showed small nuclei and fragmented nuclei, which were rarely observed in patients with nephropathy. CONCLUSIONS: These results showed that the detachment of podocytes was not directly associated with proteinuria or hematuria. The findings also suggest that GEC are damaged via an apoptotic process by chemotherapy. On the contrary, GEC may be detached through a non-apoptotic process in renal diseases.


Subject(s)
Antineoplastic Agents/adverse effects , Epithelial Cells/pathology , Glomerulonephritis, IGA/urine , IgA Vasculitis/urine , Kidney Glomerulus/cytology , Neoplasms/urine , Adolescent , Adult , Antineoplastic Agents/therapeutic use , Apoptosis , Child , Child, Preschool , Female , Fluorescent Antibody Technique , Glomerulonephritis, IGA/pathology , Humans , IgA Vasculitis/pathology , Infant , Male , Neoplasms/drug therapy , Urine/cytology
4.
Rinsho Ketsueki ; 42(6): 488-95, 2001 Jun.
Article in Japanese | MEDLINE | ID: mdl-11505528

ABSTRACT

Serial monitoring of chimerism after allogeneic hematopoietic stem cell transplantation (HSCT) can be performed easily and rapidly using PCR-based assays analyzing informative tandem repeat genetic markers. Sequential analysis of individual chimerism status was performed in 34 patients who underwent myeloablative allo-HSCT using a commercial multiplex short tandem repeat (STR) kit. Mixed chimerism (MC) was found in 14 of the patients for more than one month. The incidence of MC seemed to be dependent on the type of disease or pretransplantation regimen. There was no significant difference in relapse rates between MC and complete donor chimerism (CC) in all patients. However, the relapse rate was significantly higher in MC than in CC among patients with acute leukemia. The severity of acute graft-versus-host disease (aGVHD) was significantly reduced in the patients with MC. Most of the MC patients with hematologic malignancies had transient mixed T-lymphoid chimerism, and CC was achieved within 6 months after HSCT in such cases. Patients with MC beyond 6 months after HSCT and patients with reappearance of autologous signals (MC after CC) may have an enhanced risk of relapse.


Subject(s)
Hematologic Neoplasms/genetics , Hematopoietic Stem Cell Transplantation , Adolescent , Adult , Child , Child, Preschool , Graft vs Host Disease/etiology , Hematologic Neoplasms/therapy , Humans , Infant , Middle Aged , Tandem Repeat Sequences , Transplantation Chimera/genetics
6.
J Microencapsul ; 18(1): 29-40, 2001.
Article in English | MEDLINE | ID: mdl-11201338

ABSTRACT

TiO2 particles of various sizes were prepared by grinding in cyclohexanone, and TiO2 particulate films were obtained by depositing these TiO2 particles with various sizes onto a glass or quartz substrate. The effect of the particle size and thickness on the photocatalytic properties of the films was evaluated via oxidative degradation of gaseous 2-propanol. The initial rate of 2-propanol degradation under UV light irradiation for the films deposited with 30 nm TiO2 particles increased with increasing film thickness up to 600 nm, and reached a saturated value above this film thickness. Photocatalytic activity for the films with thickness below 600nm was larger when smaller TiO2 particles were deposited onto the substrate, due to the increase in the surface area of the particulate films. Furthermore, saturated values of the photocatalytic activity for thick films were smaller for the films deposited with smaller particles, which is mainly attributed to the change in crystal form of the particles during the grinding treatment.


Subject(s)
Titanium/chemistry , 2-Propanol/chemistry , 2-Propanol/radiation effects , Catalysis , Cyclohexanones , Membranes, Artificial , Oxidation-Reduction , Particle Size , Photochemistry , Solvents , Surface Properties , Suspensions , Ultraviolet Rays , X-Ray Diffraction
7.
Pathol Int ; 50(5): 412-6, 2000 May.
Article in English | MEDLINE | ID: mdl-10849331

ABSTRACT

A case of clear cell sarcoma (CCS) arising in the transverse colon is presented. The tumor consisted of sheets or small nests of epithelioid malignant cells possessing pleomorphic nuclei with one or more prominent nucleoli and ample clear or slightly eosinophilic cytoplasm. Some of the tumor cells contained various amounts of melanin pigments that were confirmed by histochemical and ultrastructural examinations. Immunohistochemical examination showed a positive immunoreactivity for HMB45 and S-100 protein. A metastatic nodule, which was found 9 months after surgery, showed similar histological findings to those of the primary one but lacked melanin pigments. Reverse transcriptase- polymerase chain reaction using total ribonucleic acid obtained from metastatic nodule demonstrated the presence of EWS-ATF-1 fusion gene. Based on these findings, the present case tumor is a CCS of the colon.


Subject(s)
Colonic Neoplasms/pathology , Sarcoma, Clear Cell/pathology , Aged , Antigens, Neoplasm/analysis , Colonic Neoplasms/chemistry , Colonic Neoplasms/genetics , Colonic Neoplasms/surgery , DNA Primers/chemistry , Humans , Immunohistochemistry , Male , Melanins/analysis , Oncogene Proteins, Fusion/analysis , Oncogene Proteins, Fusion/genetics , RNA, Neoplasm/analysis , Reverse Transcriptase Polymerase Chain Reaction , S100 Proteins/analysis , Sarcoma, Clear Cell/chemistry , Sarcoma, Clear Cell/genetics , Sarcoma, Clear Cell/surgery , Transcription Factors
8.
Diagn Cytopathol ; 22(5): 275-80, 2000 May.
Article in English | MEDLINE | ID: mdl-10790232

ABSTRACT

This study was designed to evaluate the utility of blasts with a clear halo around their nucleoli (BCHN) as a predictive indicator of disease progression in myelodysplastic syndromes (MDSs) and aplastic anemia (AA). Bone marrow aspirates from 75 patients with MDSs and 18 with AA were fixed in 95% ethanol solution or 10% neutral formalin and stained with the Papanicolaou method. BCHNs were detected in 57 of 75 patients with MDSs and in 10 of 18 AA patients. Disease progression was restrictedly observed in 17 patients with MDSs who had BCHNs at onset and in 1 patient with AA. The proportion of BCHNs increased with disease progression in these 16 of 17 patients with MDSs. The presence of BCHNs at onset and the increase in proportion of BCHNs during the clinical course of MDSs were significant indications for predicting disease progression.


Subject(s)
Anemia, Aplastic/pathology , Cell Nucleolus/pathology , Myelodysplastic Syndromes/pathology , Anemia, Aplastic/physiopathology , Cell Nucleolus/ultrastructure , Humans , Myelodysplastic Syndromes/physiopathology , Predictive Value of Tests , Prognosis
10.
Pediatr Int ; 41(6): 641-7, 1999 Dec.
Article in English | MEDLINE | ID: mdl-10618884

ABSTRACT

BACKGROUND: The present study was designed to evaluate the association of multidrug resistance gene (MDR1), multidrug resistance-associated protein (MRP) gene and lung resistance protein (LRP) gene expression (mRNA levels) with risk factors such as phenotype, age and leukocyte count in newly diagnosed childhood acute lymphoblastic leukemia, because biological mechanisms contributing to risk factors were not known. METHODS: Expression of the MDR1, MRP and LRP genes in leukemic cells from 40 pediatric patients was quantitated using the reverse transcriptase polymerase chain reaction method. The associations of expression of these genes with age and leukocyte count, which are known as risk factors for acute lymphoblastic leukemia (ALL), were analyzed. Moreover, the associations with clinically classified risk-related groups (high-risk ALL and low-risk ALL) were also investigated. RESULTS: No positive correlations between expression of these genes and age or leukocyte count were found. The expression of these genes was not different among clinically classified risk-related groups. CONCLUSIONS: Expression (mRNA levels) of the MDR1, MRP and LRP genes did not contribute to risk factors in newly diagnosed childhood acute lymphoblastic leukemia.


Subject(s)
Drug Resistance, Multiple/genetics , Drug Resistance, Neoplasm/genetics , Precursor Cell Lymphoblastic Leukemia-Lymphoma/genetics , Adolescent , Child , Child, Preschool , Female , Gene Expression , Humans , Infant , Male , RNA, Messenger/analysis , Reverse Transcriptase Polymerase Chain Reaction , Risk Factors , Statistics, Nonparametric
11.
Am J Nephrol ; 18(6): 504-7, 1998.
Article in English | MEDLINE | ID: mdl-9845825

ABSTRACT

For the purpose of studying glomerular injuries induced by antineoplastic drugs, the excretion of glomerular epithelial cells (GEC) was evaluated. In 13 children who received antineoplastic drugs, the excretion of GEC in urine samples was examined with an immunofluorescent study using a monoclonal antibody directed against podocalyxin, which was expressed on glomerular epithelial cells. GEC were detected in 20 of 25 chemotherapy courses. The excretion of GEC persisted until the next chemotherapy course in some cases. After an initiation of chemotherapy an increased urinary albumin-creatinine ratio (more than 2-fold) was found in 6 patients. A significant increase of N-acetylglucosaminidase was observed in 2 patients. Proteinuria and hematuria were not observed in all patients. These results indicate that glomerular injuries are frequently induced by chemotherapy independent of the tubular damage. Repeated glomerular injuries may result in late renal dysfunction.


Subject(s)
Antineoplastic Agents/adverse effects , Kidney Glomerulus/drug effects , Urine/cytology , Acetylglucosaminidase/urine , Albuminuria , Child , Child, Preschool , Creatinine/blood , Epithelial Cells , Female , Fluorescent Antibody Technique , Humans , Infant , Kidney Glomerulus/pathology , Male , Proteinuria , Sialoglycoproteins/urine , beta 2-Microglobulin/urine
12.
Leuk Lymphoma ; 31(3-4): 405-9, 1998 Oct.
Article in English | MEDLINE | ID: mdl-9869205

ABSTRACT

Competitive RT-PCR was used to determine the quantitative variation in the expression of deoxycytidine kinase (dCK) gene in childhood leukemic cells. The degree of dCK gene expression varied over a 50-fold range. In two cases in which both primary and relapsed leukemic cells were analysed, decreased expression of dCK gene was found in relapsed leukemic cells. The sequence variation analysis using bisbenzimide/polyethylene glycol electrophoresis demonstrated no sequence alteration of dCK cDNA in all cases. These results indicate that the expression of dCK gene varies in patients and suggests decreased expression of the dCK gene as one of the mechanisms responsible for clinical resistance to ara-C.


Subject(s)
Deoxycytidine Kinase/genetics , Gene Expression Regulation, Neoplastic , Precursor Cell Lymphoblastic Leukemia-Lymphoma/genetics , Adolescent , Child , Child, Preschool , DNA, Complementary/analysis , Deoxycytidine Kinase/biosynthesis , Female , Gene Expression Regulation, Enzymologic , Humans , Infant , Male , Precursor Cell Lymphoblastic Leukemia-Lymphoma/enzymology , Precursor Cell Lymphoblastic Leukemia-Lymphoma/pathology , Recurrence , Sequence Analysis, DNA
13.
Pathol Int ; 48(7): 526-35, 1998 Jul.
Article in English | MEDLINE | ID: mdl-9701015

ABSTRACT

Bone marrow aspirates from 60 patients with acute myeloid leukemia (AML) were investigated using 95% ethanol fixation Papanicolaou stained preparations. The blasts were grouped into those with a clear halo around nucleoli (BCHN) and those without a clear halo. The patients were classified into three groups according to the degree of persistent BCHN at the end of induction therapy: group 1, no BCHN; group 2, less than 1% BCHN; and group 3, 1% or more BCHN. All patients in groups 1 (17 cases) and 2 (12 cases), and 12 of 31 cases in group 3 achieved complete remission (CR). Of 17 patients in group 1, two underwent bone marrow transplantation and two died from infection. Of the 37 patients who achieved CR, relapse was observed in two of 13 patients in group 1, and in all patients in groups 2 and 3. As to the patients treated with N4-behenoyl-1-beta-D-arabinofuranosyl-cytosine + daunorubicin + 6-mercaptopurine + prednisolone (BHAC-DMP) protocol, the percentages and number of BCHN at the diagnosis of AML in group 1 were significantly lower than those of groups 2 and 3. The percentage and number of BCHN at the diagnosis of AML were significant factors for the achievement of CR and for the prediction of long-term outcome. The reduction of BCHN to less than 1% at the end of induction therapy is a good indicator for the achievement of CR, and the disappearance of BCHN is a useful target for a long-lasting first CR; conversely, the persistence of BCHN is a major adverse factor for relapse.


Subject(s)
Bone Marrow Cells/pathology , Cell Nucleolus/pathology , Leukemia, Myeloid/pathology , Acute Disease , Adolescent , Adult , Aged , Aged, 80 and over , Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Bone Marrow Cells/metabolism , Child , Child, Preschool , Cytarabine/analogs & derivatives , Cytarabine/therapeutic use , Daunorubicin/therapeutic use , Disease-Free Survival , Humans , Immunoenzyme Techniques , Ki-67 Antigen/metabolism , Leukemia, Myeloid/drug therapy , Leukemia, Myeloid/metabolism , Mercaptopurine/therapeutic use , Middle Aged , Neoplasm Recurrence, Local , Prednisolone/therapeutic use , Remission Induction , Retrospective Studies , Vincristine/therapeutic use
14.
Pathol Int ; 47(9): 608-13, 1997 Sep.
Article in English | MEDLINE | ID: mdl-9311011

ABSTRACT

The biological characteristics of a new monoclonal antibody (TO73) reacting with a vincristine-resistant human leukemic cell line (KY-VCR) were evaluated. Immunological and electron-immunological studies showed that TO73 reacted with the surface glycoprotein of KY-VCR. TO73 was found to have no effect on cell growth and intracellular uptake of vincristine. In human neoplastic cell lines, TO73 was found to react with 11 of 27 (41%) cell lines. With regard to de novo primary tumor with one exception, TO73 did not react with any of the examined primary tumor cells. The patient with TO73-positive leukemia died of induction failure due to drug resistance. Complete remission was achieved in the other leukemic patients. These results indicate that TO73 antigen may be associated with immortalization of tumor cells and poor prognosis in some cases.


Subject(s)
Antibodies, Monoclonal/pharmacology , Leukemia, Myeloid/immunology , Leukemia, Myeloid/metabolism , Membrane Glycoproteins/metabolism , Neoplasms/metabolism , Bone Marrow/metabolism , Cell Division/drug effects , Drug Resistance, Neoplasm , Flow Cytometry , Humans , Immunohistochemistry , Lymphoma/metabolism , Male , Membrane Glycoproteins/immunology , Microscopy, Electron , Middle Aged , Neuraminidase/pharmacology , Periodic Acid/pharmacology , Trypsin/pharmacology , Tumor Cells, Cultured , Vincristine/pharmacology
15.
Pathol Int ; 47(8): 512-7, 1997 Aug.
Article in English | MEDLINE | ID: mdl-9293530

ABSTRACT

YU-311 is a monoclonal antibody that reacts with a human leukemia cell line resistant for cytosine arabinoside and that identifies a 92 kDa membrane protein. The reactivity of YU-311 in normal organs, various non-hematopoietic tumors and in mast cell tumors in formalin-fixed, paraffin-embedded specimens was examined using immunohistochemical methods. In normal organs, YU-311 reacted with fundic glands of the stomach, the intercalated duct of the pancreas, the distal portion and the loop of Henle of renal tubules and tissue mast cells. Benign neoplasms of various organs showed no immunoreaction with YU-311, except for mast cell tumors. Some types of malignant neoplasms were occasionally positive against YU-311, suggesting neoplasms arising from or differentiating along normal YU-311-positive counterparts. Some other types of malignancies were rarely positive for YU-311, although their normal counterparts showed no immunoreactivity with YU-311. None of the non-epithelial tumors reacted with YU-311, except for one case of malignant melanoma. In contrast, normal tissue mast cells and their related tumors, such as urticaria pigmentosa or solitary mastocytoma, were constantly positive for YU-311. None of the non-hematopoietic human tumor cell lines examined in the present study was reactive with YU-311. These findings indicate that YU-311 is a good marker of some types of tumors and mast cell tumors and that an aberrant expression of YU-311 rarely occurs.


Subject(s)
Adenoma/immunology , Antibodies, Monoclonal/immunology , Antibody Specificity/immunology , Antigens, Neoplasm/immunology , Carcinoma/immunology , Mast-Cell Sarcoma/immunology , Antimetabolites, Antineoplastic/pharmacology , Cytarabine/pharmacology , Drug Resistance, Neoplasm , Humans , Immunohistochemistry/methods , Paraffin Embedding
16.
Ann Clin Lab Sci ; 27(4): 276-81, 1997.
Article in English | MEDLINE | ID: mdl-9210972

ABSTRACT

A monoclonal antibody (YK-2), which was previously established to react with apolipoprotein E (apoE) peptides in systemic amyloid deposits, was further characterized. Epitope of this antibody was determined to be the residue 221 to 230 of apoE. In comparison with polyclonal anti-apoE antibodies, this antibody showed strong reactivity with apoE peptides in amyloid fibril preparation but poor reactivity with native apoE protein or apoE in serum, indicating its usefulness for probing degraded apoE in amyloid deposits. Immunohistochemical studies resulted in strong reactivity for amyloid A and immunoglobulin light-chain deposits but weak for beta 2-microglobulin and beta amyloid (senile plaque) deposits. Although the association of apoE with amyloid is non-specific to the component peptide of amyloid fibrils, present findings suggest that the amount or degradation manner of apoE or the environment around the antibody epitope vary among types of amyloidosis.


Subject(s)
Amyloid/immunology , Antibodies, Monoclonal/analysis , Antibodies, Monoclonal/immunology , Apolipoproteins E/immunology , Alzheimer Disease/immunology , Alzheimer Disease/pathology , Amino Acid Sequence , Amyloid beta-Peptides/immunology , Amyloid beta-Peptides/metabolism , Animals , Antibodies, Monoclonal/blood , Binding, Competitive , Epitopes/analysis , Epitopes/immunology , Immune Sera/immunology , Immune Sera/metabolism , Immunohistochemistry , Mice , Molecular Sequence Data
17.
Leuk Lymphoma ; 26(3-4): 369-76, 1997 Jul.
Article in English | MEDLINE | ID: mdl-9322900

ABSTRACT

The relation between resistance to anticancer drugs and resistance to apoptosis has been investigated in the human leukemic cell line(KY-821) and its drug-resistant sublines. Under serum depletion conditions, drug-resistant cell lines showed apoptotic resistance when compared with the parental cell line. Drug resistant cell lines also showed resistance to apoptosis when treated with all-trans retinoic acid. DNA fragmentation was low in drug resistant cell lines under both stimulations. Flowcytometry analysis did not show any alterations of the Fas antigen, p53, bcl-2 and c-myc protein expression toward inhibition of apoptotic response in drug-resistant sublines. These results indicate that drug-resistant leukemic cells still show resistance to apoptosis-inducing stimulation such as poor nutrition and differentiation-inducing agents.


Subject(s)
Antineoplastic Agents/pharmacology , Apoptosis/drug effects , Leukemia/drug therapy , Leukemia/metabolism , Tretinoin/pharmacology , Blotting, Western , Culture Media, Serum-Free , DNA, Neoplasm/metabolism , Drug Resistance, Neoplasm , Electrophoresis , Humans , Leukemia/pathology , Proto-Oncogene Proteins c-bcl-2/biosynthesis , Proto-Oncogene Proteins c-myc/biosynthesis , Tumor Cells, Cultured , Tumor Suppressor Protein p53/biosynthesis , fas Receptor/biosynthesis
18.
Acta Paediatr Jpn ; 39(3): 368-70, 1997 Jun.
Article in English | MEDLINE | ID: mdl-9241904

ABSTRACT

A 14-month-old boy with refractory idiopathic thrombocytopenic purpura (ITP), who was successfully treated with pulsed high-dose oral dexamethasone therapy is reported. The platelet count increased after six scheduled courses of treatment (10 mg/day x 4 days, six courses). Twenty-four months later, the platelet count remained over 10.0 x 10(4)/microL. No obvious side effects were observed during or after the therapy. This treatment could be taken into consideration not only for adults but also for young children with refractory ITP. It is effective, safe, easy to administer, patient comfort is taken into consideration, and hospitalization duration and costs are minimized.


Subject(s)
Anti-Inflammatory Agents/therapeutic use , Dexamethasone/therapeutic use , Glucocorticoids/therapeutic use , Purpura, Thrombocytopenic, Idiopathic/drug therapy , Anti-Inflammatory Agents/administration & dosage , Dexamethasone/administration & dosage , Glucocorticoids/administration & dosage , Humans , Immunoglobulins, Intravenous/therapeutic use , Infant , Male , Prednisolone/therapeutic use , Treatment Failure
19.
Eur J Pediatr ; 156(4): 266-8, 1997 Apr.
Article in English | MEDLINE | ID: mdl-9128808

ABSTRACT

UNLABELLED: A 287 base pair insertion/deletion polymorphism in intron 16 of the angiotensin I converting enzyme (ACE) gene was examined by polymerase chain reaction in 36 Kawasaki disease patients (16 without coronary aneurysm, 20 with coronary aneurysm). A polymorphism in the ACE gene was characterized by three genotypes: two D alleles (genotype DD), two I alleles (genotype II), and heterozygous allele (genotype DI). Genotype II was found in 65% of the patients with aneurysm and 12.5% of those without aneurysm (P < 0.01, odds ratio 13.0, 95% confidence intervals). CONCLUSION: Patients with Kawasaki disease and coronary aneurysm more often than expected had the genotype II suggesting that reactions induced by the type of ACE polymorphism predispose to coronary aneurysm formation.


Subject(s)
Coronary Aneurysm/complications , Mucocutaneous Lymph Node Syndrome/genetics , Peptidyl-Dipeptidase A/genetics , Polymorphism, Genetic , Age of Onset , Child , Child, Preschool , Female , Gene Frequency , Humans , Infant , Japan/epidemiology , Male , Mucocutaneous Lymph Node Syndrome/epidemiology , Sex Distribution
20.
Acta Paediatr Jpn ; 39(1): 1-5, 1997 Feb.
Article in English | MEDLINE | ID: mdl-9124040

ABSTRACT

The aim of the present study was to determine the distribution of the insertion/deletion polymorphism of angiotensin I converting enzyme (ACE) gene in Japanese children. In addition, the relationship between this polymorphism and serum ACE levels in the same population were analyzed. Insertion/deletion polymorphism located in intron 16 of the ACE gene was examined by polymerase chain reaction in Japanese children aged 10-15 years. Allele frequencies were 0.64 for the insertion allele and 0.36 for the deletion allele in 122 subjects. No association was found between genotypes in this polymorphism and the level of systolic or diastolic blood pressure. A significant relationship between this polymorphism and serum ACE activity was observed. These results suggest that interindividual variability of serum ACE level is strongly influenced by the ACE genotype as early as in childhood.


Subject(s)
Asian People/genetics , Peptidyl-Dipeptidase A/blood , Peptidyl-Dipeptidase A/genetics , Polymorphism, Genetic , Adolescent , Child , Female , Gene Deletion , Gene Frequency , Genotype , Humans , Japan , Male , Polymerase Chain Reaction
SELECTION OF CITATIONS
SEARCH DETAIL
...